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ABSTRACT
Objective To evaluate the effects of external inspections 
on (1) hospital emergency departments’ clinical processes 
for detecting and treating sepsis and (2) length of hospital 
stay and 30- day mortality.
Design Incomplete cluster- randomised stepped- wedge 
design using data from patient records and patient 
registries. We compared care processes and patient 
outcomes before and after the intervention using 
regression analysis.
Setting Nationwide inspections of sepsis care in 
emergency departments in Norwegian hospitals.
Participants 7407 patients presenting to hospital 
emergency departments with sepsis.
Intervention External inspections of sepsis detection and 
treatment led by a public supervisory institution.
Main outcome measures Process measures for sepsis 
diagnostics and treatment, length of hospital stay and 30- 
day all- cause mortality.
Results After the inspections, there were significant 
improvements in the proportions of patients examined by 
a physician within the time frame set in triage (OR 1.28, 
95% CI 1.07 to 1.53), undergoing a complete set of vital 
measurements within 1 hour (OR 1.78, 95% CI 1.10 to 
2.87), having lactate measured within 1 hour (OR 2.75, 
95% CI 1.83 to 4.15), having an adequate observation 
regimen (OR 2.20, 95% CI 1.51 to 3.20) and receiving 
antibiotics within 1 hour (OR 2.16, 95% CI 1.83 to 2.55). 
There was also significant reduction in mortality and 
length of stay, but these findings were no longer significant 
when controlling for time.
Conclusions External inspections were associated with 
improvement of sepsis detection and treatment. These 
findings suggest that policy- makers and regulatory 
agencies should prioritise assessing the effects of their 
inspections and pay attention to the mechanisms by 




External assessment of healthcare providers 
is in widespread use as a policy strategy to 
foster improvement in the quality of care.1 
WHO defines assessment as an external insti-
tutional strategy and divides it into three 
subcategories: accreditation, certification 
and supervision.2 According to WHO, accred-
itation generally refers to external assessment 
of an organisation by an accreditation body, 
certification is usually used to describe external 
assessment of compliance with standards 
published by the International Organisa-
tion for Standardisation (ISO) and supervi-
sion refers to an authoritative monitoring of 
healthcare providers’ compliance with 
minimum standards often set by legislation.2
These assessment schemes represent 
heterogeneous, complex processes that 
consist of a set of activities that are intro-
duced into varying organisational and regula-
tory contexts, and their origin and objectives 
can differ.3 They share an important defining 
element in that: “some dimensions or char-
acteristics of a health care provider organisa-
tion and its activities are assessed or analysed 
against a framework of ideas, knowledge, or 
measures derived or developed outside that 
organisation”.4 The phrase “external” also 
implies that the assessment is initiated and 
Strengths and limitations of this study
 ► This is the first large- scale study using a robust de-
sign to evaluate the effects of external inspections 
on clinical care.
 ► As it was not possible to design a randomised con-
trolled study, we used a stepped- wedge design, 
allowing the inspections to proceed as usual while 
we assessed effects based on data collected by the 
inspectors.
 ► Even though we adjusted for a range of known con-
founders, there is a risk that unknown external fac-
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conducted by an organisation external to the one being 
assessed.
External assessments can serve different purposes. 
They can represent a control strategy, emphasising 
whether providers meet certain standards, thereby 
promoting accountability and transparency in a regu-
lated society.5 However, they can also represent an 
improvement strategy, based on the assumption that 
externally promoted adherence to evidence- based stan-
dards contributes to higher quality of healthcare.4 This 
assumption, however, seems to lack a clear scientific foun-
dation. Although research suggests that external assess-
ment can have a positive impact on an organisation level, 
for example, on improved leadership, quality systems 
and professional development,6–9 less is known about 
the impacts of external assessment on the quality of care. 
According to a Cochrane review of the literature, there 
is a paucity of high- quality controlled evaluations on this 
topic.10
External assessments are contemporary, real- world 
events that involve autonomous actors, including health-
care providers, inspecting organs and policy- makers. 
The complexity of the settings in which external assess-
ments take place may explain why only three randomised 
controlled studies have been performed to evaluate their 
effect on quality of care: two small- scale studies11 12 and one 
study13 whose methods have been criticised for leading 
to unreliable conclusions.10 None of these studies found 
improvements in patient care resulting from external 
assessments. Three other studies that used time- series 
design and a before- and- after design also did not find 
improvement in performance indicators of care delivery 
that could be attributed to external assessments.14–16 
Considering the widespread and growing use of external 
assessments and the resources spent on conducting and 
participating in them, there is a need for high- quality 
studies evaluating their effectiveness on quality of care.10
The overall aim of this study is to evaluate the effect 
of statutory inspections at the patient level by assessing 
detection and treatment of sepsis in emergency depart-
ments in Norwegian hospitals. According to WHO’s clas-
sification, this represents an example of assessment in the 
supervision category. We use the term “external inspec-
tion”, in line with the Cochrane review.10
Sepsis is a major public health challenge and a leading 
cause of death.17 The inspections in the present study 
assessed adherence to standards for sepsis care that 
have been shown to be associated with improved patient 
outcomes.18 19 Specifically, the aim of our study was to 
evaluate the effects of the inspections on hospital emer-
gency departments’ clinical processes for detecting and 
treating sepsis and on length of hospital stay and 30- day 
mortality.
METHODS
To study the effects of the inspections, we used a prag-
matic cross- sectional incomplete stepped- wedge design 
with cluster- level randomisation at the regional level. The 
study included data from all hospitals subject to the sepsis 
inspections.
Setting
The Norwegian healthcare system is publicly funded, and 
it scores high on Organization for Economic Co- opera-
tion and Development (OECD) quality indicators.20 All 
provision of health services in Norway is regulated by 
legislation. Healthcare services should be safe, effective 
and provided in accordance with sound professional 
practice, and all organisations that provide healthcare 
services must have a quality management system to 
ensure that healthcare services are provided in accor-
dance with the legal requirements.21 The organisation 
of specialised emergency care is based on the principle 
of equal access to services. The government designates a 
specific geographical area to each hospital, within which 
the hospital is responsible for providing emergency care 
to the whole population. Patients within the designated 
area in need of hospital emergency services are admitted 
to the hospital after referral or prior contact with general 
practitioners or other medical professionals.22
The Norwegian Board of Health Supervision and its 
regional- level subordinate, the County Governors, are 
mandated by law to ensure that healthcare is provided 
in accordance with the legal requirements. An important 
way of fulfilling this mandate is conducting thematic, 
nationwide inspections. The themes of these inspections 
are decided on the basis of information about risk and 
vulnerability. Norway does not have a mandated system of 
hospital accreditation, and there are no other regulatory 
agencies or government bodies supervising the provision 
of health services.
Intervention
As an intervention, we studied inspections in 24 hospitals 
in Norway. The inspections addressed early detection and 
treatment of patients with sepsis admitted to the hospi-
tals’ emergency departments. The inspection campaign 
lasted from April 2016 to March 2018.
The sepsis inspections were planned and directed by 
the Norwegian Board of Health Supervision, and they 
were carried out by six inspection teams from the County 
Governors. Each team performed four inspections within 
a time frame of about 8 weeks in four geographically prox-
imate hospitals. The inspections were headed by expe-
rienced team leaders who were trained in performing 
inspections. The teams consisted of a minimum of four 
inspectors with medical and legal expertise, including 
an independent senior consultant physician in internal 
medicine or critical care medicine.
The inspections were based on the ISO’s procedures for 
system audits23 and encompassed three main phases: the 
announcement of the inspection and collection of rele-
vant data, the site visit, and reporting and follow- up. The 
information and data reviewed during the inspections 
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with management staff and personnel with responsibili-
ties related to care for patients with sepsis, and patient 
records. During the follow- up period, the inspection 
teams conducted verification of patient records at 8 and 
14 months after the initial inspection.
On the basis of all the information and gathered data, 
the inspection team assessed whether the emergency 
department’s clinical processes for sepsis detection and 
treatment were in line with the regulatory standard. A 
key part of the inspections was identifying and pointing 
out underlying reasons for substandard performance of 
the clinical system delivering care to patients admitted 
with sepsis. The inspection team also assessed to what 
extent the hospital management had fulfilled their 
legal obligation to implement a functional management 
system that monitors, and when necessary improves, the 
quality of sepsis detection and treatment. In this way, 
the inspections challenged the quality of performance 
through addressing the managerial level’s responsi-
bility for ensuring good practice through providing 
an expedient organisational framework for delivering 
sound professional practice. The inspection teams’ 
findings and conclusions were presented in reports 
that were made publicly available on the Internet (one 
of the reports is provided here as an example—see 
online supplemental material 1). The reports focused 
on identified non- conformities in the quality of care 
for patients with sepsis. All inspections found instances 
of substandard performance, the most common being 
delay in antibiotic treatment. After each site visit, there 
was a follow- up phase. During this phase, the hospital 
management were held responsible for developing and 
implementing necessary measures to improve substan-
dard performance.
Table 1 provides an overview of the key elements of the 
intervention.
Study design, participants and data collection
The inspection campaign was mandated to include all 18 
counties in Norway, and each County Governor decided 
which hospitals to inspect in their region. The main 
inclusion criterion was hospital size because substandard 
care in larger hospitals would potentially affect more 
patients. The hospitals selected for inspection comprised 
all university and regional hospitals and a geographically 
based selection of local hospitals. They included 24 out 
of 50 hospitals in Norway with emergency services, and 
served 75% of the total population.
This study was developed in conjunction with the plan-
ning of the inspections. It was not feasible to establish an 
unexposed control group, and, for practical reasons, the 
intervention could not be delivered simultaneously to 
the entire study population. We therefore used a prag-
matic cross- sectional incomplete stepped- wedge design 
with cluster- level randomisation where all inspected 
hospitals were included in the study.24 25 The inspections 
were carried out sequentially in the 24 hospitals over 
12 months from April 2016 to March 2017. The County 
Governors notified the hospitals of the inspections 2 to 
6 months in advance of the site visits. The order of the 
inspections was randomised at the regional level using 
a computer- generated list of random numbers; each 
inspection team received a randomly assigned time slot 
of 8 weeks during which they were to conduct the inspec-
tion of four hospitals in their region. Figure 1 provides an 
overview of the trial profile. We have previously published 
the full protocol of the study, including the rationale for 
the use of the stepped- wedge design.25
We based inclusion into the study on the standard defi-
nition of sepsis in use when the study was developed.26 
Accordingly, the criteria were clinically suspected infec-
tion on presentation to the emergency department and 
at least two systemic inflammatory response syndrome 
Table 1 Key elements of the intervention
Time in months Activity
1 Inspection team announces inspection and requests the hospital to submit information
2 Inspection team reviews records of patients with sepsis and collect relevant data for the inspection criteria. 
Data are collected for two time periods, baseline (September 2015) and right before the site visit. Inspection 
team reviews information from hospital and prepares for the site visit
3 Two- day site visit at the hospital with interviews of key personnel
At the end of the site visit, the inspection team presents the preliminary findings, and the hospital can 
comment on these preliminary findings
4–5 The inspection team writes a preliminary report of their findings. The hospital can comment on the report
6 The inspection team sends the final report to the hospital
Continuously The hospital plans and implements improvement measures
11 Follow- up audit (8 months after site visit). The inspection team reviews records of patients with sepsis and 
collect the same kinds of data as they did prior to the site visit
Report on findings from audit. Require the hospital to implement necessary changes
17 Follow- up audit (14 months after site visit). The inspection team reviews records of patients with sepsis and 
collect the same kinds of data as they did prior to the site visit.
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signs, not including high leucocyte counts. The included 
patients were aged 18 years or older.
We used a two- step approach to identify eligible patients. 
First, we searched the Norwegian Patient Registry using 
a predefined list of the ICD-10 diagnostic codes most 
commonly used in Norway to classify sepsis and infections 
(online supplemental material 2).27 The Patient Registry 
contains diagnostic and therapeutic codes for all hospital 
admissions. The search produced a list of patients who had 
been discharged from the participating hospitals with a 
sepsis and/or infection code, together with an identifica-
tion number that enabled us to access the corresponding 
health records. Second, we assessed the individual patient 
records for eligibility by collecting information about 
these patients’ clinical status on presentation to the emer-
gency department.
We collected data for four time periods for each 
hospital: two before the inspection and two after the 
inspection. In the first data collection period, we 
included patients admitted to all hospitals before 1 
October 2015. This was before the Norwegian Board of 
Health Supervision announced the national inspection 
campaign. The second collection period varied across 
the hospitals. The endpoint of this period was the day 
prior to the site visit at each hospital. The third and 
fourth time periods were also specific to each hospital, 
encompassing the 8 and 14 months after the initial site 
visit, respectively. For each time period, we included the 
last 83 consecutive patients who fulfilled the inclusion 
criteria on presentation to the emergency department. 
For all patient records, we gathered data from the elec-
tronic health records about patient age, sex, admission 
and discharge dates, and the presence of organ failure. 
Following national evidence- based guidelines,26 28 we 
defined organ failure as fulfilling at least one of the 
following criteria at arrival to the emergency department: 
oxygen saturation <90% or PaO2/FiO2 <40 kPa, altered 
mental status, urine output <0.5 mL/kg/h or increase in 
serum creatinine >50 µmol/L, international normalised 
ratio >1.5 or activated partial thromboplastin time >60 s, 
platelet count <100 or 50% reduction in previous 3 days, 
serum bilirubin >70 mmol/L, serum lactate >4 mmol/L, 
blood pressure <90 mm Hg systolic, mean arterial pres-
sure <60 mm Hg or fall in mean arterial pressure >40 mm 
Hg. For the first 33 patients, we also collected data on 
diagnostic measures and treatment given. The data on 
diagnostic measures and treatment were gathered by the 
inspection teams and used as audit evidence during the 
inspection and follow- up visits.
It was not possible to blind health personnel to the 
intervention, as information about the inspections was 
publicly known and health personnel participated in 
interviews and during follow- up. Nor was it possible to 
blind inspectors and researchers reviewing health records 
to the intervention or control condition, as information 
about time and dates was critical to the review.
We obtained data on 30- day all- cause mortality and the 
Charlson Comorbidity Index29 for the included patients 
from the Norwegian Patient Registry by connecting data 
using a unique personal identifier. For patients who had 
multiple admissions, we used data relating to the first 
admission.
We performed power calculations using the stepped-
wedge function30 in Stata/IC, V.14.0 (StataCorp, College 
Station, TX, USA). For the measures of care delivery, we 
powered the study to detect an absolute improvement of 
70% to 83% and a reduction in mortality of 5% to 11%. 
We assumed an intra- cluster correlation of 0.05, and type 
I and type II errors were assumed to be 0.05 and 0.20, 
respectively. See the study protocol for further details of 
the power calculations.25
Study outcomes and covariates
Previous research has emphasised the importance of 
early recognition of sepsis in enabling timely treat-
ment31 32 and demonstrated an association between 
compliance with evidence- based standards and improved 
outcomes.18 19 33 The Norwegian Board of Health Super-
vision has identified key clinical processes involved in 
the recognition and treatment of sepsis by examining 
international guidelines26 34 and soliciting advice from 
experts on sepsis. The indicators we used as study vari-
ables for measures of care delivery (see box 1) were 
operationalised from the inspection criteria used by the 
Board of Health Supervision. We defined mortality as all- 
cause mortality within 30 days of hospital admission, and 
we defined length of stay as the number of days from 
admission date to discharge date. In the study protocol, 
we included the percentage of patients receiving oxygen 
therapy as a measure of care delivery. However, informa-
tion on oxygen therapy was not systematically recorded 
in the electronic patient records, so we had to exclude 
this variable from our analysis.
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Statistical analysis
We compared patient care delivery and outcomes before 
and after the inspection. Patient characteristics were 
compared using univariate analyses with Pearson’s χ2 test 
or the Wilcoxon rank- sum test.
Using logistic regression, we assessed the strength of 
the associations between having had an inspection and 
patients receiving adequate care, and we report the 
associations as ORs. To analyse changes in the patient 
outcome variables from before the inspection to after the 
inspection, we used logistic models for 30- day mortality 
and negative binomial models for length of stay. Because 
the patient data were sampled from different hospitals, 
we used mixed- effects models with hospital number 
included as a random effect to account for clustering.
In our analysis of changes in diagnosis and treat-
ment, we report both unadjusted and adjusted models. 
In the adjusted models, we controlled for selections of 
the following variables: age, organ failure, Charlson 
Comorbidity Index, sex, seasonality and calendar year. 
We based the choice of control variables for each model 
on the Akaike information criteria score. Non- significant 
adjustment variables were kept in the models if doing so 
improved the overall model fit (see online supplemental 
material 3). Age and Charlson Comorbidity Index were 
entered into the model as linear terms, organ dysfunc-
tion and sex were entered as categorical variables, and 
seasonality and calendar year were entered as categorical 
variables. For patient outcomes, we report estimates from 
models with the adjustment variables age, organ dysfunc-
tion, Charlson Comorbidity Index and sex, with and 
without additional adjustment for calendar year.
Among the 3082 health records from which we had 
collected data on diagnostic and treatment processes, 
there was missing information on several of the process 
variables. Data on the diagnostic variables, complete vital 
measures, blood samples, lactate, observation regimen 
and supplemental diagnostic procedures were, to a great 
extent, automatically incorporated in the electronic 
patient records if they were performed. For these vari-
ables, we therefore recoded missing data as the proce-
dure not having been performed within the given time 
limit. The other variables with missing information were 
blood culture taken prior to antibiotic treatment (5% 
missing), timely assessment by a physician (24% missing), 
time to triage (11% missing), time to fluid administration 
(29% missing) and time to administration of antibiotics 
(7% missing). For these variables, we could not assume 
a specific reason for missing observations. We decided 
not to impute missing data on these variables because 
running multiple imputation on dependent variables is 
not recommended in the absence of an auxiliary variable 
that correlates strongly with the imputation variable, as 
was the case here.35
The statistical analyses were performed using Stata/IC, 
V.16 (StataCorp).
Patient and public involvement
Patient organisations participated in a reference advi-
sory group for the overall research programme, which 
included this study. They were involved from the planning 
stage on, but they did not directly participate in devel-
oping the research questions or outcome measures used 
in this article. We used their inputs to inform the overall 
study design. Patient organisations strongly advocated the 
importance of disseminating the study findings to rele-
vant parties. The Norwegian Board of Health Supervi-
sion has held a national, public conference for hospitals, 
government agencies and patient representatives where 
we presented preliminary study findings.
RESULTS
A total of 7407 patients with sepsis were included in the 
study. Figure 2 shows the flow of patients through the 
study.
The median age of patients in the pre- inspection and 
post- inspection groups were 70 and 73 years, respectively. 
Box 1 Study measures
Measures of health care delivery
 ► Proportion of patients triaged within 15 min of arrival at the emer-
gency department.*
 ► Proportion of patients assessed by a physician in accordance with 
the urgency specified in the initial triage.
 ► Proportion of patients whose vital signs were measured within 
1 hour of arrival at the emergency department.
 ► Proportion of patients whose blood lactate was measured within 
1 hour of arrival at the emergency department.
 ► Proportion of patients from whom blood samples† were drawn with-
in 1 hour of arrival at the emergency department.
 ► Proportion of patients from whom blood cultures were taken before 
the administration of antibiotics.
 ► Proportion of patients with adequate supplementary investigations 
to detect the focus of infection.
 ► Proportion of patients who were adequately observed‡ while in the 
emergency department.
 ► Proportion of patients who were adequately discharged from the 
emergency department for further treatment in the hospital (written 
statement indicating patient status, treatment and further actions).
 ► Percentage of patients who received intravenous fluids within 1 hour.
 ► Proportion of patients who received antibiotics within 1 hour.
Outcome measures
 ► Length of stay in hospital.
 ► 30- day all- cause mortality.
*Norwegian hospitals are required to establish a system for prioritising patients 
admitted to emergency departments. The scales used for this are based on 
the South African Triage Scale and the Rapid Emergency Triage and Treatment 
System.
†Leucocyte count, haemoglobin, C reactive protein, creatinine, electrolytes, 
platelet count and glucose.
‡‘Adequate’ is defined as continuous observation, as well as measurement 
and documentation of vital signs at least every 15 min in critically ill patients 
with sepsis and organ failure, measurement and documentation of vital signs 
every 15 min if a physician has not examined a patient with sepsis but no 
documented organ failure, and every 30 min after first examination in such 
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A larger proportion of patients in the post- inspection 
group had organ failure (39.3%), compared with the pre- 
inspection group (36.6%) (see table 2).
Changes in diagnosis and treatment
Relative to the pre- inspection group, the post- inspection 
group had higher odds for being examined by a physi-
cian within the time frame set in triage (OR 1.28, 95% CI 
1.07 to 1.53), higher odds for having complete set of vital 
measurements taken within 1 hour (OR 1.78, 95% CI 1.10 
to 2.87), higher odds for having measured lactate within 
1 hour (OR 2.75, 95% CI 1.83 to 4.15), higher odds for 
having adequate observation regimen (OR 2.20, 95% CI 
1.51 to 3.20) and higher odds for antibiotics being admin-
istered within 1 hour (OR 2.16, 95% CI 1.83 to 2.55). 
Figure 3 displays changes in process measures before and 
after the inspections.
Changes in patient outcomes
On average, the length of stay was significantly shorter 
in the post- inspection group (6.2 days) than in the pre- 
inspection group (7.1 days). There was also a signifi-
cant reduction in all- cause mortality within 30 days of 
admission, from 11.1 in the pre- inspection group to 10.5 
in the post- inspection group. After controlling for time, 
neither of these changes were statistically significant (see 
table 3).
DISCUSSION
In the adjusted analyses, five of the measures of health-
care delivery showed significant improvement from 
before to after the inspection. The improvements were 
observed in aspects of care delivery that are of great 
importance to patients. We found significant improve-
ment in time to treatment with antibiotics, which is associ-
ated with increased survival in patients with severe sepsis 
and septic shock.18 19 Moreover, we also found that signif-
icant improvement for timely assessment by a physician, 
lactate measurement, adequate observation and taking a 
complete set of vital signs are all key clinical processes in 
the early detection of sepsis. The first three mentioned 
measures are significantly associated with earlier treat-
ment with antibiotics.36 The measures that were improved 
coincided with the main targets of the inspections and the 
key measures that the hospitals were required to improve 
following the inspections.
Although there were improvements also in the other 
measures of healthcare delivery and in the patient 
outcomes, 30- day mortality and length of stay, these 
changes were not statistically significant after adjusting 
for time. This implies that we cannot specifically attribute 
these improvements to the inspections.
Strengths and limitations
The main strength of our study is that it comprised a 
robust evaluation of the effects of external inspections on 
quality of care in real- world settings. To the best of our 
knowledge, the present research is the largest and most 
comprehensive study of inspection effects using a cluster- 
randomised research design.
It is, nevertheless, important to discuss whether the 
changes in the observed measures are attributable to 
causes other than the inspections. To do this, we address 
questions relating to coding and documentation, 
Figure 2 Patient flow.
Table 2 Patient characteristics
Factor Before inspection After inspection P value
N 3813 3594
Sex Male 1939 (50.9%) 1881 (52.3%) 0.2*
Female 1874 (49.1%) 1713 (47.7%)
Age, years Median (IQR) 70 (56–81) 73 (60–82) <0.001†
Mean (SD) 66.8 (18.8) 68.9 (18.5)
Organ failure 1387 (36.6%) 1409 (39.3%) 0.015*
Charlson Comorbidity Index Median (IQR) 2 (1–4) 2 (1–4) 0.49†
*Pearson’s χ2 test.
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unknown confounders, contamination by other initia-
tives and time adjustments.
In 2016, the Society of Critical Care Medicine and the 
European Society of Intensive Care Medicine launched 
a new sepsis definition.37 This initiative may have led to 
changes in the coding practice for sepsis. However, inclu-
sion in the present study was based on the assessment of 
the clinical status of patients with infection at arrival in 
the emergency department. Patients at Norwegian hospi-
tals are discharged with one main diagnosis and up to 
seven secondary diagnoses. If a patient has had any kind 
of infection during the hospital stay, this will be coded as 
a primary or secondary diagnosis at discharge. Therefore, 
changes in the coding practice for sepsis could not have 
biased our analyses. There is a risk that by oversight, no 
infection or sepsis code was assigned in a health record, 
resulting in that the record was not included in our 
screening. However, there is no reason to believe that the 
relative frequency of such errors would differ between the 
pre- inspection and post- inspection data. Therefore, such 
errors are not likely to have influenced our estimates of 
the inspection effects.
For some of the clinical processes examined in this 
study, the degree of documentation in the electronic 
patient records improved after the inspections. To assess 
whether the observed improvements could be caused by 
improvements in documentation, we analysed the asso-
ciation between time to treatment and missing data on 
diagnostic procedures. We found that having missing data 
on diagnostic procedures was associated with prolonged 
time to treatment (see online supplemental material 3). 
Given the association between time to diagnosis and time 
to treatment, we expect observations with missing data 
to be, on average, more delayed, compared with obser-
vations for which we have data. Thus, improvements in 
the process variables are, in all probability, not caused by 
improvements in documentation.
Due to the preconditions and constraints provided by 
doing the study in a real- world setting, it was not possible 
to conduct a randomised controlled trial.25 As with 
any observational study, there was an inherent risk of 
confounding from unknown factors. A limitation of our 
study is that we did not have data on severity of sepsis in 
the form of commonly used severity scores like SAPS 2 
(simplified acute physiology score) or APACHE II (acute 
physiology and chronic health evaluation), or a detailed 
organ failure assessment score like SOFA (sequential 
organ failure assessment). We did control for age, pres-
ence of organ failure and comorbidity, which are three 
important variables associated with severity of sepsis.38
Another potential source of confounding was influence 
on emergency department practices by other external 
factors. The stepped- wedge design reduced the risk of 
such biases. The overlap period where clusters of hospi-
tals switched from control to intervention according to a 
randomised schedule encompassed 1433 patients. In this 
period, other factors besides the inspections that could 
contribute to the observed improvements would affect 
both the intervention group and the control group simul-
taneously. In addition, we also controlled for seasonality 
and year of admittance.
When it comes to confounding by external factors, a 
particular concern in our study was the possibility of other 
nationwide initiatives influencing sepsis management at 
Figure 3 Process measures before and after inspection.
Table 3 Patient outcomes before and after inspection
Before After





30 days from admission
424 (11.1%) 377 (10.5%) 0.81 (0.69 to 0.95)‡ 1.25 (0.86 to 1.80) ‡§
Length of stay in days, mean 
(SD)
7.1 (7.8) 6.2 (6.1) 0.87 (0.84 to 0.90)¶ 0.94 (0.86 to 1.03)¶
n 3813 3594 7371 7371
*Adjusted for age, organ dysfunction, sex and Charlson Comorbidity Index.
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the emergency departments. There were no other regu-
latory initiatives that could affect these practices, as the 
Norwegian Board of Health Supervision and the County 
Governors are the only bodies assessing compliance with 
regulatory standards. During the period the present study 
was conducted, the Norwegian government initiated a 
voluntary sepsis- management improvement programme. 
Some of the included hospitals chose to participate in 
this programme. We specifically analysed the possible 
impacts of participation in this programme. Participation 
did not have a significant effect in terms of explaining 
the improvements in the process measures, and it had a 
negligible impact on the estimated sizes of the inspection 
effects. We therefore chose not to include participation in 
the patient safety programme as a control variable.
‘Anticipatory effects’—stemming from improvement 
initiatives by the hospitals made in preparation of an 
upcoming inspection—may also represent a source of 
bias. Such effects can be considered as constituent parts 
of the total impact of the inspections.39 Anticipatory initia-
tives could have influenced the emergency departments’ 
processes in the timespan between announcement and 
inspection. As some of the pre- inspection data stems from 
this period, we could expect our estimates of the inspec-
tion effect to be attenuated by the influence of anticipa-
tory effects on the pre- inspection data.
Finally, the time variable may introduce a bias to the 
regression model which results in an underestimated 
effect of the intervention. Due to the constraints of 
doing the research in a real- world setting, the majority 
of observations were collected from the periods before 
and after inspection where, respectively, none and all of 
the hospitals had been inspected. This results in correla-
tion between time and intervention. There are too few 
observations of inspected hospitals in the early period of 
the study and of uninspected hospitals in the later period 
to consistently estimate the true effect of time, indepen-
dent of the intervention effect. There were significant 
reductions in mortality and length of stay after the inspec-
tions when adjusting for age, organ dysfunction, sex and 
Charlson Comorbidity Index. When additionally adjusting 
for time, there were no longer any significant reductions. 
The lack of significant effects on patient outcome was 
not expected, as previous research has suggested that the 
improvments we observed in care delivery would lead to 
improved patient outcomes,18 and challenges with model-
ling of secular trends is one potential explanation for this 
finding.
Interpretation of findings and comparison with other studies
In contrast to previous studies, which were unable to 
detect association between external inspections and 
improvement in quality of care,11–13 we found improve-
ments in key measures of care delivery, including time to 
treatment. The lack of significant associations between 
inspection and the outcome measures when adjusting 
for time might be due to the heterogeneity of the 
patient group included in the study. The effect of earlier 
treatment on reduced mortality has been documented 
in patients with severe sepsis and septic shock.18 As only 
a proportion of patients in our study had severe sepsis 
and septic shock, it seems reasonable to expect more 
modest reduction in mortality. Furthermore, we need to 
be careful when reviewing the results from the models 
where time is included as an adjustment variable. Regard-
less of whether the improvements in patient outcomes in 
this study can be attributed to the inspections or not, we 
found significant improvements in key processes of care 
delivery including diagnostic processes, observation and 
time to treatment. These are key processes of care delivery 
that will enable medical personnel to make sound clin-
ical decisions and initiate treatment processes that have 
shown to be important to patient outcomes.18 36
The fact that our study showed such improvements after 
the inspections, whereas previous studies did not, might 
be explained by contextual factors and how the inspec-
tions were conducted. WHO has described a generic 
framework for how external assessment can contribute 
to quality improvement: (1) development of standards 
addressing requirements that will lead to improvement 
in patient care, (2) reliable identification of performance 
gaps, (3) involvement of managers and professionals in 
developing action plans in response to the assessment, 
and (4) implementation of the plans in a way that lead to 
improvement.2
Several aspects of the Norwegian sepsis inspections are 
noteworthy in relation to this framework. Compared with 
the previously studied inspections,15 16 the sepsis inspec-
tions in Norway had a narrower target with requirements 
that were closely related to patient care. Previous work 
has suggested that, to contribute to improvement, the 
inspection process should be translated into something 
meaningful and understandable for clinical practice.14 39 
The inspections in our study explicitly targeted the early 
detection and treatment of sepsis, which are crucial for 
patients and highly relevant and understandable from a 
clinical perspective. The methods used during the inspec-
tions provided the hospitals with reliable and valid data 
on how their emergency departments performed in terms 
of the early detection and treatment of patients with 
sepsis.36 The hospitals were also provided with quantita-
tive and qualitative data that could shed light on possible 
reasons for substandard performance of the clinical care 
delivery system.
The inspections addressed the hospital management 
staff’s responsibility for ensuring evidence- based practice 
through providing an expedient organisational frame-
work for the clinical care delivery system. During the 
two follow- up visits, the management was provided with 
feedback on the progress of the improvement efforts 
and held accountable for implementing the necessary 
changes. Previous research has indicated that holding the 
inspected organisation accountable for implementing 
changes can contribute to the creation of momentum for 
implementing the necessary improvement measures.39 
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towards quality of care delivery, this emphasis on following 
up and holding the hospital management accountable 
for making changes to the clinical care delivery system 
may have contributed to the improvements we found.
Adequate discharge, the one process measure which 
showed a negative trend after the inspections, was not 
emphasised during the inspections because it was not 
directly related to early detection of the sepsis diagnosis 
and treatment. Neither was it a measure that the hospi-
tals were required to report on following the inspection. 
The fact that this measure was not emphasised during 
the inspection process might in part explain the negative 
trend. This finding is also in line with previous research 
indicating that inspections can have a negative impact 
on measures that are not within the main purview of the 
inspections.15
Our findings also bring into view a larger concern 
regarding internal and external assessment schemes. 
There is always a risk that the use of quantitative indica-
tors instigates managerial ‘gaming’, whereby hospitals put 
efforts into improving their scoring on specific indicators 
rather than on improving the system delivering care.40 
The inspections in our study used a set of performance 
indicators that together provided information about how 
the clinical system delivering care for patients with sepsis 
performed as a whole.36 Improving these indicators would 
thus contribute to an overall systemic improvement in the 
quality of care for patients with sepsis. If the inspection 
maintains a clear focus on the overall goal of quality of 
care by assessing a set of performance indicators that 
matters for patient care, gaming behaviour by inspected 
hospitals can be dissuaded.
CONCLUSIONS
Comparing a range of measures before and after inspec-
tion, we found improvements in both processes and 
patient outcomes following the inspections. Though the 
improvements in patient outcomes cannot be specifically 
attributed to the inspections, we find substantial improve-
ments in care delivery for patients with sepsis. Our 
findings indicate that inspections can be used to foster 
large- scale improvements in quality of care. However, it 
does not mean that conducting inspections necessarily 
leads to improvements. Inspections are complex interven-
tions, and one can assume that their efficacy depends on 
the context in which they are conducted and how they are 
planned and implemented. Policy- makers and inspecting 
bodies should therefore prioritise assessing the effects of 
their inspections and pay attention to the mechanisms by 
which inspections might contribute to improving care for 
patients.
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